Clinical Trial Update: Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of SGLT-2 inhibition on myocardial fibrosis and inflammation in type 2 diabetes patients using cardiac MRI; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Fibrosis
• Myocardial Inflammation
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Washington | Conditions: Type 2 Diabetes Mellitus, Myocardial Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2023-12-29